NLRP6
NACHT, LRR and PYD domains-containing protein 6
Also known as: CLR11.4, NALP6, NLRP6_HUMAN, PAN3, PYPAF5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P59044
- Gene
- NLRP6
- Ensembl
- ENSG00000174885
- Chromosome
- 11
- Canonical length
- 892 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
The protein encoded by this gene binds arginine-vasopressin and may be involved in the arginine-vasopressin-mediated regulation of renal salt-water balance. The encoded protein also mediates inflammatory responses in the colon to allow recovery from intestinal epithelial damage and protects against tumorigenesis and the development of colitis. Finally, this protein can increase activation of NF-kappa-B, activation of CASP1 through interaction with ASC, and cAMP accumulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2013]
Canonical amino-acid sequenceUniProt
892 residues, UniProt reviewed canonical sequence.
>P59044|NLRP6
1 MDQPEAPCSS TGPRLAVARE LLLAALEELS QEQLKRFRHK LRDVGPDGRS IPWGRLERAD
61 AVDLAEQLAQ FYGPEPALEV ARKTLKRADA RDVAAQLQER RLQRLGLGSG TLLSVSEYKK
121 KYREHVLQLH ARVKERNARS VKITKRFTKL LIAPESAAPE EAMGPAEEPE PGRARRSDTH
181 TFNRLFRRDE EGRRPLTVVL QGPAGIGKTM AAKKILYDWA AGKLYQGQVD FAFFMPCGEL
241 LERPGTRSLA DLILDQCPDR GAPVPQMLAQ PQRLLFILDG ADELPALGGP EAAPCTDPFE
301 AASGARVLGG LLSKALLPTA LLLVTTRAAA PGRLQGRLCS PQCAEVRGFS DKDKKKYFYK
361 YFRDERRAER AYRFVKENET LFALCFVPFV CWIVCTVLRQ QLELGRDLSR TSKTTTSVYL
421 LFITSVLSSA PVADGPRLQG DLRNLCRLAR EGVLGRRAQF AEKELEQLEL RGSKVQTLFL
481 SKKELPGVLE TEVTYQFIDQ SFQEFLAALS YLLEDGGVPR TAAGGVGTLL RGDAQPHSHL
541 VLTTRFLFGL LSAERMRDIE RHFGCMVSER VKQEALRWVQ GQGQGCPGVA PEVTEGAKGL
601 EDTEEPEEEE EGEEPNYPLE LLYCLYETQE DAFVRQALCR FPELALQRVR FCRMDVAVLS
661 YCVRCCPAGQ ALRLISCRLV AAQEKKKKSL GKRLQASLGG GSSSQGTTKQ LPASLLHPLF
721 QAMTDPLCHL SSLTLSHCKL PDAVCRDLSE ALRAAPALTE LGLLHNRLSE AGLRMLSEGL
781 AWPQCRVQTV RVQLPDPQRG LQYLVGMLRQ SPALTTLDLS GCQLPAPMVT YLCAVLQHQG
841 CGLQTLSLAS VELSEQSLQE LQAVKRAKPD LVITHPALDG HPQPPKELIS TFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NLRP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 38 nTPM
- duodenum: 38 nTPM
- spleen: 3.5 nTPM
- liver: 2.5 nTPM
- appendix: 2.1 nTPM
- kidney: 1.3 nTPM
Single-cell type
- enterocytes: 60 nCPM
- neutrophils: 56 nCPM
- enteric transient amplifying cells: 11 nCPM
- t-cells: 9.2 nCPM
- innate lymphoid cells: 6.9 nCPM
- enteric stem cells: 6.3 nCPM
Immune cell
- neutrophil: 16 nTPM
- non-classical monocyte: 4.6 nTPM
- naive CD8 T-cell: 2.3 nTPM
- naive CD4 T-cell: 1.8 nTPM
- memory CD4 T-cell: 1.6 nTPM
- MAIT T-cell: 1.4 nTPM
Brain region
- cerebral cortex: 8.4 nTPM
- medulla oblongata: 1.8 nTPM
- pons: 1.5 nTPM
- hypothalamus: 1.2 nTPM
- white matter: 1 nTPM
- thalamus: 0.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.76
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute inflammatory response
- acute inflammatory response to antigenic stimulus
- antiviral innate immune response
- defense response to Gram-positive bacterium
- defense response to virus
- host-mediated modulation of intestinal microbiota composition
- necroptotic process
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of inflammatory response to antigenic stimulus
- negative regulation of toll-like receptor signaling pathway
- negative regulation of type II interferon production
- neutrophil-mediated killing of gram-positive bacterium
- positive regulation of inflammatory response
- positive regulation of interleukin-18-mediated signaling pathway
- protein homooligomerization
- pyroptotic inflammatory response
- regulation of autophagy
- regulation of inflammatory response
- wound healing
- NLRP6 inflammasome complex assembly
- regulation of mucus secretion
Molecular functions
- ATP binding
- double-stranded RNA binding
- lipopolysaccharide binding
- lipoteichoic acid binding
- molecular condensate scaffold activity
- pattern recognition receptor activity
- peptide binding
- signaling adaptor activity
- vasopressin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DAPIN domain
- NACHT nucleoside triphosphatase
- Death-like domain superfamily
- P-loop containing nucleoside triphosphate hydrolase
- Leucine-rich repeat domain superfamily
- NOD1/2, winged helix domain
- NACHT, LRR and PYD domains-containing protein, helical domain HD2
- NLRP family, innate immunity and inflammation regulators
- PAAD/DAPIN/Pyrin domain
- NACHT domain
- NLRC4 helical domain HD2
- NOD2 winged helix domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NLRP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NLRP6 as an antibody target. Whether an autoantibody or antibody against NLRP6 could matter depends on whether native NLRP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NLRP6 is annotated at the cell surface, where native NLRP6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NLRP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...